Skip to main content

Usana Health Sciences Inc

USNA
Exchange
NYSE
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0000896264

No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Usana Health Sciences Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of USNA: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1612154−5
Shares10.2M14.0K10.2M+65.3K (+0.6%)
Value$494.0M$673.5K$463.0M−$30.3M (−6.1%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Usana Health Sciences Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to USNA in Q2 2024
InstitutionSharesValue% of portfolio
Winton Group Ltd19,663$889.6K0.06%
Toroso Investments, LLC13,162$595.4K0.01%
Marshall Wace, LLP11,602$524.9K0.00%
Guggenheim Capital LLC10,533$476.5K0.00%
SG Americas Securities, LLC7,522$340.0K0.00%
State of Wisconsin Investment Board6,719$304.0K0.00%
Corebridge Financial, Inc.6,599$298.5K0.00%
Mirae Asset Global ETFs Holdings Ltd.6,508$294.4K0.00%
Campbell & CO Investment Adviser LLC6,170$279.1K0.02%
Millennium Management LLC4,827$218.4K0.00%
EntryPoint Capital, LLC2,565$116.0K0.05%
Amundi2,236$100.6K0.00%
Qube Research & Technologies Ltd1,672$75.6K0.00%
Aquatic Capital Management LLC1,200$54.3K0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.535$24.2K0.00%
Bessemer Group Inc124$6.00K0.00%
SRS Capital Advisors, Inc.54$2.44K0.00%
Innealta Capital, LLC41$1.85K0.00%
Capital Advisors, Ltd. LLC18$1.00K0.00%
Umb Bank N A16$7240.00%
Larson Financial Group LLC2$900.00%

Sold out (26)

Institutions that held Usana Health Sciences Inc at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held Usana Health Sciences Inc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding USNA in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG11,845$574.5K
Shell Asset Management Co2,181$99.0K